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The central circadian pacemaker is located in the hypothalamus of mammals, but essentially the same oscillating
system operates in peripheral tissues and even in immortalized cell lines. Using luciferase reporters that allow
automated monitoring of circadian gene expression in mammalian fibroblasts, we report the collection and analysis of
precise rhythmic data from these cells. We use these methods to analyze signaling pathways of peripheral tissues by
studying the responses of Rat-1 fibroblasts to ten different compounds. To quantify these rhythms, which show
significant variation and large non-stationarities (damping and baseline drifting), we developed a new fast Fourier
transform–nonlinear least squares analysis procedure that specifically optimizes the quantification of amplitude for
circadian rhythm data. This enhanced analysis method successfully distinguishes among the ten signaling compounds
for their rhythm-inducing properties. We pursued detailed analyses of the responses to two of these compounds that
induced the highest amplitude rhythms in fibroblasts, forskolin (an activator of adenylyl cyclase), and dexamethasone
(an agonist of glucocorticoid receptors). Our quantitative analyses clearly indicate that the synchronization
mechanisms by the cAMP and glucocorticoid pathways are different, implying that actions of different genes
stimulated by these pathways lead to distinctive programs of circadian synchronization.
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Introduction
Among temporally regulated processes, the circadian clock
is unique in that it operates precisely on a cycle of
approximately 24 h to regulate time-dependent processes
such as sleep–wake cycles and body temperature ﬂuctuations.
Molecular components of the mammalian circadian clock
have been identiﬁed and cloned [1]. They constitute at least
two interlocked negative feedback loops: one loop is
composed of PER1/PER2 and CRY1/CRY2 as repressing
factors that inhibit their own transcription, and CLOCK/
BMAL1 transcription factors as positive elements to activate
clock-controlled genes from E-boxes on genetic regulatory
elements; the other loop is an interlocked circuit in which
REV-ERBa and RORa regulate bmal1 transcription [2]. The
core clock components have been extensively studied, but
many questions remain: (1) how circadian oscillators are
entrained; (2) how the individual oscillators that are present
throughout the body are coordinated; and (3) what molecular
mechanisms underlie these resetting and synchronization
events.
While it might be simplistically thought that the ‘‘master’’
oscillator in the suprachiasmatic nucleus (SCN) of the
hypothalamus could govern the rhythmic expression of
peripheral tissues by driving overt rhythms in physiology
and behavior, data from mammals, Drosophila, and other
organisms have long suggested the existence of multi-
oscillators that were organized in a hierarchical fashion
[3,4]. Studies showing that isolated peripheral tissues from
Drosophila [5], zebraﬁsh [6], rats [4], and even immortalized
mammalian cultured cells such as Rat-1 ﬁbroblasts [7] and
NIH3T3 cells [8] are capable of generating circadian
rhythmicity of gene expression in vitro have provided
experimental evidence for hierarchically organized multi-
oscillators. In addition to the theoretical concept of
oscillators being expressed throughout the organism, the fact
that tissue culture cells contain autonomous functional clocks
has practical signiﬁcance. For example, whereas SCN tissue is
difﬁcult to obtain and manipulate, cell cultures have
important advantages: they are easy to maintain, accessible
to molecular genetic tools, and can produce the large amount
of material that is necessary for biochemical assays. Because
of these advantages, cultured cells have provided an excellent
alternative to the SCN for the study of the molecular and
biochemical mechanisms of mammalian circadian systems in
vitro [8–20].
To facilitate the collection of highly time-resolved data
from cell cultures, we and others developed an in vitro
bioluminescence reporter system to study the dynamics of
temporal expression of clock genes in mammals [13,15,20–
23]. This noninvasive automated monitoring system is a
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ever, quantitative analysis of circadian rhythms in peripheral
tissues and cultured cells is challenging for a variety of
reasons. First, the response of cell cultures to different
treatments (e.g., drugs, hormones) is highly variable. Second,
the rhythms of the cell cultures exhibit damping (i.e. variance
non-stationarities; see [4,15]). Third, these rhythms often
show unstable baseline shifting (i.e., mean non-stationarities)
that changes from experiment to experiment, or even from
sample to sample. In the context of studying input signaling
pathways, it is particularly challenging to statistically differ-
entiate between residual low-amplitude rhythms (such as
those stimulated by solvent controls or media changes) and
high-amplitude rhythms that have been induced by drugs/
hormones of interest. Thus, we set out to develop a
computational method to analyze the data from cell culture
experiments for (1) the presence of rhythmicity, (2) the
signiﬁcance level of the rhythmicity, and (3) the ‘‘strength’’ of
the resulting oscillation.
We used fast Fourier transform–nonlinear least squares
(FFT-NLLS) analysis [24,25] coupled with detrending to
remove mean non-stationarities and variance non-stationar-
ities that are consistently encountered in the Rat-1 cell data.
Analysis in this manner permits assignment of values to
parameters characterizing the period and phase as well as the
degree of rhythmicity via relative amplitude error (RAE). To
quantitatively assess oscillatory ‘‘strength,’’ we developed a
method for analyzing the amplitude of the rhythms. Amplitude
analyses have historically been avoided as gauges of circadian
pacemakers because the amplitude of an output rhythm will
be a reﬂection of not only the pacemaker’s amplitude, but
also of the output pathway characteristics, including tran-
sients, masking, and other amplitude effects [26]. The
importance of amplitude has been appreciated in the
modeling of circadian oscillations [27,28] and its role in
photoperiodic induction [29], but for physiological and
molecular studies, phase and period have traditionally been
considered to be the most reliable indicators of pacemaker
action to avoid complications of the observed output assay. In
particular, by virtue of elegant ‘‘two-pulse phase response
curve’’ analyses [3,30], phase-shifting properties were deter-
mined to be accurate indicators of the underlying oscillator
that were not altered by output considerations. However, our
current understanding of the circadian clockwork has
advanced to the stage where reasonable molecular candidates
that could act as state variables have been identiﬁed. We
herein describe reporters of promoter activity for the clock
genes mper1, mper2, and bmal1; the transcription rates of these
genes are state variables in current transcription/translation
feedback models of the mammalian clock [31]. Therefore,
quantifying the amplitude of the luminescence rhythms
expressed by these reporters as a gauge of the amplitude of
the underlying oscillator may contribute important informa-
tion at a ﬁner level of detail than previously possible.
Our primary goal in the current study lies in elucidating
the molecular mechanisms of input signaling and cellular
synchronization in the mammalian circadian clock. To
examine the precise expression patterns induced by various
drug/hormone treatments, we enlisted new luminescence
reporters using the mper2, bmal1, and dbp promoters, thereby
extending beyond the repertoire of previous reporter systems
[15]. Among ten drug/hormone treatments, the enhanced
FFT-NLLS analysis identiﬁed (1) 50% horse serum, (2)
dexamethasone (Dex), (3) forskolin (Fsk), and (4) epidermal
growth factor (EGF) as being most effective in generating
high-amplitude rhythms in Rat-1 cells. The association of
signaling strength, promoter activation, and the initiation of
rhythmicity was further examined in the cases of Fsk and Dex.
Our quantitative analyses revealed that the mode of rhythm
initiation by Fsk is dramatically different from that by Dex,
and this difference is likely to be due to different molecular
communication pathways.
Results
Modified Luciferase Reporter System in Rat-1 Cells
We previously reported the generation of a stable Rat-1
reporter cell line harboring the ﬁreﬂy luciferase cDNA (Luc)
driven by a 3.0-kb mper1 promoter [15]. While this reporter
cell line has been useful in examining rhythmic mper1
promoter activity, the amplitude of its oscillation is relatively
low and therefore has not been optimal for distinguishing the
properties of different rhythm-initiating treatments.
To improve the reporter system, we modiﬁed both the
promoter region and the luciferase region. For the promoter
region, we ﬁrst generated and tested a stable reporter line
using a longer mper1 regulatory region (6.8 kb) that contained
ﬁve canonical E-boxes and was used to make a Pmper1::Luc
transgenic reporter rat [4,32] (Figure 1). Although the basal
expression level increased with this reporter, there was no
signiﬁcant change in the oscillatory amplitude. Therefore, we
tested the promoters of other genes: Pmper2 (1.7 kb from the
transcription start site [33]), Pbmal1 (0.9-kb promoter region
[ 776 to þ99][34]), and Pdbp (5.0-kb regulatory region
containing introns 1 to 3 [ 579 to þ4430 as a translational
fusion] [35,36]). The temporal expression patterns of Rat-1
ﬁbroblast cells that were stably transfected with these
reporters all exhibited more robust circadian expression
PLoS Computational Biology | www.ploscompbiol.org October 2006 | Volume 2 | Issue 10 | e136 1249
Synopsis
The circadian biological clock controls the adaptation of animals and
plants to the daily environmental cycle of light and darkness. As
such, this clock is responsible for jet lag and has consequences for
mental health (e.g., depression), physical health (e.g., athletic
performance and the timing of heart attacks), and social issues
(e.g., shift work). The central circadian pacemaker is located in the
hypothalamus of the mammalian brain, but essentially the same
oscillating system operates in nonneural tissues. Using luciferase, an
enzyme that emits light, the authors could monitor circadian gene
expression in mammalian fibroblasts via luminescence emission that
is controlled by the biological clock. Using this method, they report
the collection and analysis of precise rhythmic data from these cells.
These methods were used to analyze signaling pathways by
studying the responses of fibroblasts to a variety of different
treatments, including drugs, growth factors, and serum. The authors
developed a new analysis procedure that specifically optimizes the
quantification of amplitude for cyclic data to analyze these rhythms.
This enhanced analysis method successfully distinguishes among
the various signaling treatments for their rhythm inducing proper-
ties. The quantitative analyses clearly indicate that the synchroniza-
tion mechanisms by the cyclic AMP and glucocorticoid pathways are
different. Therefore, these pathways lead to distinctive programs of
circadian synchronization.
Circadian Gene Expression in Fibroblaststhan those of the Pmper1 reporters (Figure 1). Unexpectedly,
the mper2 promoter, which has no canonical E-boxes but only
a single noncanonical E-box at  23 relative to the tran-
scription start site [37,38], showed high-amplitude rhythms.
Of this second generation of reporters, we chose Pmper2::-
dLuc for further studies in this paper, because (1) this
reporter combination exhibited consistently robust oscilla-
tions, and (2) the mPER2 protein is one of the critical core
clock components that has been implicated in resetting of the
clock [39]. For this study, one reproducibly high expression
line was selected (line no. 3–72, called ‘‘Rat1/Pmper2::dLuc’’
hereafter).
The original Pmper1::Luc construct [15] used a native ﬁreﬂy
luciferase reporter. When the half-life of this luciferase
reporter was assessed by inhibiting protein synthesis with
cycloheximide (50 lg/ml), it exhibited a half-life of 4.38 6
0.16 h (n ¼ 4) in the stably transfected Rat-1 cells. Because
other groups have reported that the half-life of native
luciferase in cultured SCN slices from Pmper1::Luc transgenic
mice is 1.2–1.4 h [40,41], we concluded that the relatively
slower turnover of native luciferase in our system is
characteristic of the Rat-1 ﬁbroblast cells. To enable the
measurement of more dynamic changes in circadian gene
expression in vivo, we replaced the native reporter (‘‘Luc’’)
with luciferase that has been destabilized by the fusion of a
PEST sequence from a mouse ornithine decarboxylase gene
to the C-terminal end of ﬁreﬂy luciferase cDNA (‘‘dLuc’’)
[13,16]. Using Rat-1 cells that were stably transfected with a
Pmper1::dLuc construct, we measured the half-life of dLuc to
be 2.83 6 0.39 h (n ¼ 5). Although the half life was shortened
by only 1.5 h, the major beneﬁt of using dLuc is that it shows
no apparent accumulation of inactive luciferase in the
absence of the luciferin substrate that causes the high basal
activity of wild-type Luc during the ﬁrst 12 h of recording
(Figure 2; see also [42] for a description of this phenomenon
in other systems). Therefore, dLuc is particularly useful for
studies in which the ﬁrst several hours of recordings are
important (e.g., for monitoring signaling, synchronization,
and rhythm initiation).
Quantitative Analysis of Damping Rhythms in Mammalian
Cells
Many different stimuli are capable of initiating rhythmicity
in cultured cells. These include serum [7], Dex [43], Fsk [44],
PMA, ﬁbroblast growth factor (FGF), and EGF [8,10], calcium
ionophores [10], endothelin-1 (ET-1) [45], glucose [12], and
prostaglandin E2 (PGE2) [17]. The characteristics of the
rhythms induced by these different treatments have been
reported from a variety of studies from different labs (using
different techniques and cell lines), and it is therefore
impossibletocompare the relative efﬁcacy ofthese treatments
for initiating circadian rhythmicity. In Rat-1 ﬁbroblasts,
serum, Dex, Fsk/cAMP responsive element binding protein
(CREB), PMA, FGF, EGF, calcium, and glucose signaling
pathways are known to be operating [7,10,12,43,44]. The ET-1
response pathway is also present in Rat-1 cells (unpublished
data). NIH3T3 cells respond to PGE2 [17], implying that this
pathway exists in NIH3T3 cells, but it is not known if this
pathway is operative in Rat-1 ﬁbroblasts. To quantitatively
characterize the signaling pathways involved in the initiation
of rhythmicity of Rat-1 ﬁbroblast cells, Rat1/Pmper2::dLuc cells
wereexposedtotenpreviouslyreportedtreatmentsfor2hand
assayed for the appearance of circadian rhythms in the real-
time reporting system. As shown in Figure 3, we observed very
signiﬁcant variation in the subsequent rhythmic expression
patterns induced by the different treatments.
The principal advantages of the real-time monitoring of
luminescent cell cultures are the ability to obtain data that
are highly resolved in time and to measure multiple samples
in high-throughput mode. However, quantitative analyses of
circadian rhythmicity in the Rat-1 ﬁbroblast system are
Figure 1. Bioluminescence Rhythms from Various Reporter Constructs
That Were Stably Transfected into Rat-1 Fibroblasts
Traces from three individual clones are shown for each reporter. Time 0 is
the onset of 2-h Fsk treatment. All of the luminescence traces shown in
this article, with the exception of Figure 4, are raw data that have not
been manipulated. RLU/min: relative light units per minute. (A) Rat-1/
Pmper1::dLuc (3.0 kb mper1 promoter). (B) Rat-1/Pmper1::dLuc (6.8 kb
mper1 promoter). (C) Rat-1/Pmper2::dLuc. (D) Rat-1/Pbmal1::dLuc. (E) Rat-
1/Pdbp::dLuc.
DOI: 10.1371/journal.pcbi.0020136.g001
Figure 2. Comparison of Native Wild-Type Luciferase (Luc) versus
Destabilized Luciferase (dLuc)
Three individual clones are shown in each graph. Time 0 is the onset of 2-
h Fsk treatment. (A) Pmper2::Luc reporter. Note the high luciferase
activity at the beginning of the monitoring. (B) Pmper2::dLuc reporter.
Note the absence of high luciferase activity at the beginning of the assay.
DOI: 10.1371/journal.pcbi.0020136.g002
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in the oscillations (i.e., variance non-stationarities). In
addition to damping, these Rat-1 rhythms also exhibit a
strong tendency for baselines to drift (i.e., mean non-
stationarities). Furthermore, as shown by Figure 3 as well as
by our previous report [15], different treatments evoke
variable circadian gene expression patterns, and even the
solvent controls or medium changes induce a certain degree
of rhythmicity that is difﬁcult to differentiate from some of
the experimental treatments.
To analyze these time-series data, we employed step-wise
quantiﬁcation methods as follows: (1) detrending the lumi-
nescence time series data to extract rhythmic components; (2)
FFT-NLLS analysis coupled with an RAE assessment to
quantitatively determine rhythmicity; (3) estimation of period
and phase by FFT-NLLS; and (4) a comparative analysis of
oscillatory strength by deriving a measure of absolute
amplitude and of normalized amplitude. FFT-NLLS is a
multicomponent cosine ﬁt analysis designed to objectively
extract periods and phases from relatively noisy data sets at a
user-speciﬁed conﬁdence level (usually 95%) [25]. Most
importantly, FFT-NLLS is coupled to a statistical assessment
of the rhythmicity by a measure of RAE [25]. In addition to
the period, phase, and RAE, we were also interested in
calculating the magnitude of the observed luminescence
oscillations, as we found that there was a distinct trend in the
amplitude of circadian expression induced by various treat-
ments (Figure 3). Differentiating gene expression patterns on
the basis of magnitudes of oscillatory amplitude allows
discrimination of weak versus strong synchronizing treat-
ments. We therefore developed a method to assess the
absolute amplitude and the normalized amplitude as
described in Materials and Methods and Figure 4. This
amplitude estimation successfully differentiated the effects of
various treatments (Table 1 and see below).
As shown in Figure 3, some ‘‘control’’ treatments exhibited
low-amplitude rhythms. In order to statistically judge
whether these rhythms are signiﬁcant or not, we used a
reporter construct that is known a priori to be arhythmic to
deﬁne an RAE threshold (as in [46]). As shown in Figure 5, by
processing the time-series data from stable Rat-1 lines
expressing luciferase under the control of the promoter
from the SV40 gene (Rat1/Psv40::dLuc) which has been
reported to be constitutively active [13], the critical RAE
was determined to be 0.123 (see Materials and Methods for
details). The traces shown in Figure 5 are representative of
the large variability exhibited by the Psv40::dLuc reporter.
From this point forward, Rat-1 samples whose RAE value was
,0.123 were accepted as rhythmic at the 95% conﬁdence
level.
Quantitative Analysis of Rhythms Induced by Various
Treatments, Especially Fsk and Dex
Using the analytical procedures described above, we
quantiﬁed the rhythms induced by various treatments, and
examined the relationship between signaling pathways and
initiation of rhythmicity in Rat1/Pmper2::dLuc cells (Figure 3
and Table 1). All the treatments induced a signiﬁcant level of
rhythmicity (RAE , 0.123). Among the ten compounds tested,
horse serum, Dex, Fsk, and EGF were the most effective in
generating rhythms with large oscillatory amplitude (Figure
6); Fsk induced a relatively higher degree of rhythmicity (RAE
¼ 0.029; Table 1) than other treatments. In Figure 6,
‘‘normalized amplitude’’ gives the best indication of the
efﬁcacy of Fsk, possibly because the overall luminescence
level of Fsk-treated cultures tends to be low and therefore the
unnormalized amplitude is depressed.
Among these four efﬁcacious treatments, we focused on
Fsk and Dex for further analysis, as they induced the highest
amplitude rhythms in Rat-1 ﬁbroblasts (Table 1 and Figure
6B). In addition, the actions of both Fsk and Dex have been
well characterized. Fsk is an activator of adenylyl cyclase in
the cAMP signaling pathway and a potent inducer of CREB
phosphorylation, and Dex is an analog of the endogenous
ligand (glucocorticoid) for the glucocorticoid receptor (GR), a
transcription factor that belongs to a nuclear receptor
superfamily.
Solvent controls (0.1% DMSO and 0.001% EtOH) induced
expression patterns that were possibly rhythmic (Figure 7A
and 7C). According to the FFT-NLLS analysis, however, the
rhythmicity in these DMSO/EtOH samples was barely
Figure 3. Fibroblast Rhythms Initiated by Various Treatments
Confluent Rat1/Pmper2::dLuc cells were treated for 2 h, then lumines-
cence monitoring was begun. Time 0 is the onset of each treatment.
DMSO (0.1%) is the solvent control for 1 lM ionomycin, 1 lM PMA, and
10 lM Fsk. Serum (0%) is a control for 50% horse serum. EtOH (0.001%) is
the solvent control for 100 nM Dex. DMEM is the solvent control for 100
lM 8-bromo-cAMP, 30 nM EGF, 25 ng/ml bFGF, 30 nM ET-1, and 1 lM
PGE2. Two representative traces from one experiment are shown in each
graph.
DOI: 10.1371/journal.pcbi.0020136.g003
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One of the traces depicted in Figure 7 is shown. Raw data were first detrended by subtracting a 24-h moving average with uniform weight from raw
data to produce zero-mean, zero-slope data. These subtracted data (DTR space) are further divided by the standard deviation to report the normalized
detrended data in the SND space. These SND data then had a variance of 1, and were analyzed by FFT-NLLS to obtain period, phase, and RAE values.
The figure shows an example of the fitted curve (green line, detrended raw data; red line, FFT-NLLS fitted curve). Based on these period and phase
estimates, FFT-NLLS is performed on the subtracted data in the DTR space to solve for amplitude (a) between the fixed time range (36–60 h was used).
DOI: 10.1371/journal.pcbi.0020136.g004
Table 1. Summary of Quantification Analysis of Experiments in Figure 3
Treatment RAE Rhythmic Sample N
(Total N)
Period (h) Phase (h) Amp (a) Norm Amp
(a/Mean y)
0% serum 0.084 6 0.027 6 (7) 22.48 6 0.34  6.38 6 1.72 212.4 6 119.9 0.075 6 0.035
50% HS 0.044 6 0.022 7 (7) 22.65 6 0.21  3.46 6 1.04 622.0 6 135.3 0.191 6 0.039
t test 0.0165
a 0.3314 0.0021
a 0.0005
a 0.0007
a
0.001% EtOH 0.088 6 0.052 5 (7) 22.66 6 0.27  7.69 6 0.98 345.3 6 80.9 0.155 6 0.053
100 nM Dex 0.050 6 0.008 7 (7) 22.50 6 0.18  9.18 6 0.47 819.0 6 116.5 0.399 6 0.072
t test 0.0721 0.4088 0.0032
a 0.0021
a , 0.0001
a
0.1% DMSO 0.084 6 0.044 6 (7) 22.73 6 0.07  7.52 6 1.02 326.0 6 71.9 0.134 6 0.043
1 lM ionomycin 0.057 6 0.025 7 (7) 22.47 6 0.25  5.04 6 1.15 432.4 6 109.3 0.155 6 0.051
1 lM PMA 0.071 6 0.032 6 (7) 23.17 6 0.48  6.34 6 0.93 442.3 6 155.7 0.156 6 0.038
10 lM Fsk 0.029 6 0.006 7 (7) 22.76 6 0.13  2.52 6 0.69 452.1 6 235.1 0.272 6 0.013
ANOVA 0.0161
a 0.0017
a , 0.0001
a 0.4815 , 0.0001
a
Dunnett’s
a (DMSO vs. Fsk) (DMSO vs. PMA) (DMSO vs. ion)
(DMSO vs. Fsk)
(DMSO vs. Fsk)
DMEM 0.068 6 0.033 7 (8) 22.78 6 0.26  7.45 6 0.97 330.9 6 64.5 0.133 6 0.037
100 lM cAMP 0.070 6 0.024 7 (7) 22.56 6 0.40  6.71 6 1.01 286.4 6 66.1 0.111 6 0.035
30 nM EGF 0.063 6 0.015 6 (6) 22.59 6 0.44  7.10 6 0.73 607.5 6 197.9 0.186 6 0.034
25 ng/ml bFGF 0.065 6 0.021 7 (7) 22.76 6 0.21  8.07 6 0.51 452.7 6 138.6 0.169 6 0.031
30 nM ET-1 0.069 6 0.041 7 (8) 22.82 6 0.20  5.79 6 0.49 400.2 6 90.5 0.156 6 0.032
1 lM PGE2 0.085 6 0.053 7 (8) 22.83 6 0.26  7.66 6 1.05 410.7 6 99.0 0.154 6 0.042
ANOVA 0.8706 0.4041 0.0002
a 0.0005
a 0.0075
a
Dunnett’s
a (DMEM vs. ET-1) (DMEM vs. EGF) (DMEM vs. EGF)
Onset of the stimulation is used as a reference point. Phase was defined as described in Protocol S1. Oscillatory amplitude (a) and normalized amplitude (‘‘Norm Amp’’) were calculated
between hours 36–60 as explained in Materials and Methods. Means 6 SD are shown (N¼6–8 from two to four independent experiments; column 3 shows the total number of samples in
parentheses and the number of rhythmic samples without parentheses).
aSignificance (p , 0.05) in two-sided t test, or ANOVA followed by Dunnett’s multiple comparisons test. Most samples were collected in media prepared from DMEM from Sigma,
contributing to higher RAE and amplitude values in each control than in Tables 2 and 3.
DOI: 10.1371/journal.pcbi.0020136.t001
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Individual DMSO/EtOH samples that exceeded the ‘‘rhyth-
micity threshold’’ showed only a minimal oscillatory ampli-
tude (Table 2). These RAE results are in close agreement and,
hence, consistent with our empirical determination of 0.123
as an effective RAE threshold for rhythmic determination.
On the other hand, when stimulated by 10 lM Fsk and 100 nM
Dex for 2 h, Rat1/Pmper2::dLuc cells exhibited a high degree of
rhythmicity (average RAE ¼ 0.050 and 0.051, respectively) as
well as high-amplitude oscillations that were signiﬁcantly
stronger than either control sample (Figure 7 and Table 2).
Close inspection of period, phase, and amplitude between
Fsk-treatment and Dex-treatment revealed two character-
istics: (1) both the absolute amplitude and the normalized
amplitude were consistently larger for Dex-initiated rhythms
than for Fsk-initiated rhythms (Table 2), and (2) there was a
signiﬁcant phase angle difference elicited by the two treat-
ments—the phase of the Dex-initiated rhythms was delayed
by 8.37 h relative to that of the Fsk-initiated rhythms (p ,
0.0001).
To further analyze the Fsk- and Dex-stimulated rhythms,
we extended the assay to a detailed time-course analysis. A
simple medium change (as indicated by treatment time¼0h )
initiated weak oscillations, but the degree of rhythmicity and
amplitude of those rhythms were substantially less signiﬁcant
than those of Fsk- or Dex-stimulated cells, albeit just below
our empirical RAE cutoff value of 0.123 (Table 3; average RAE
¼0.105). Treatments with either Fsk or Dex (even for only 30
min) initiated signiﬁcant oscillations (Figure 8 and Table 3).
There was a signiﬁcant difference between the periods of Fsk-
vs. Dex-stimulated rhythms for 1-h treatments (Table 3, and
also in Table 1), but these period differences were not
signiﬁcant for 0.5-, 2-, or 4-h treatments (nor were the periods
of Fsk- vs. Dex-stimulated rhythms signiﬁcantly different in
Table 2). In addition to the observations noted for Figure 7,
longer-duration treatments of Fsk elicited higher-amplitude
oscillations (Figure 8 and Figure 9, ANOVA p ¼ 0.030 among
Fsk-treated samples). On the other hand, Dex treatments
provoked the strongest oscillatory amplitude for 30-min
treatments, and the oscillatory amplitude did not signiﬁcantly
increase with longer treatments, suggesting that 30-min
treatments were already saturating (Figure 8 and Figure 9,
ANOVA p¼0.91 among Dex-treated samples). Moreover, the
oscillatory amplitude of Dex-induced rhythms was consis-
tently larger than with Fsk-induced rhythms (Figure 8 and
Figure 9). In contrast to Fsk treatments, which downregulated
mper2 promoter activity soon after washout, mper2 promoter
activity continued to climb for several hours after the
termination of Dex treatments (Figure 7 and Figure 8). This
phenomenon may relate to the observation that the phase of
Dex-induced rhythms was consistently delayed compared to
that of Fsk-induced rhythms (7.44 h later in the case of 2-h
treatments with Fsk vs. Dex; Figure 8 and Table 3). When cells
were treated with both Fsk and Dex, the ﬁnal phase was
Figure 5. Representative Traces of the Rat-1 Cells Stably Transfected with
Psv40::dLuc
Time 0 is the onset of each treatment. Traces from three separate
transfections are shown. (A) Rat-1/Psv40::dLuc cells treated with 10 lM
Fsk for 2 h. (B) Rat-1/Psv40::dLuc cells treated with 100 nM Dex for 2 h.
DOI: 10.1371/journal.pcbi.0020136.g005
Figure 6. Histogram Representation of the Oscillatory Amplitude
Calculations in Table 1
Error bars are 6 S.D. *Statistical significance (p , 0.05) as compared to
each control. **p , 0.005; ***p , 0.0005. (A) Absolute oscillatory
amplitude. (B) Normalized oscillatory amplitude.
DOI: 10.1371/journal.pcbi.0020136.g006
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Circadian Gene Expression in Fibroblastsintermediate between that by Fsk or Dex (4.7 h later than the
Fsk-only phase and 2.3 h earlier than the Dex-only phase; see
below). These results clearly suggest that the mechanism
underlying synchronization by Fsk is different from that of
Dex.
Kinetics of Acute Promoter Responses Stimulated by Fsk
and Dex
The per1 gene has been implicated in phase-resetting, and
indeed, per1 transcription can be induced by a variety of
signals [10,33]. The per1 gene might also be a useful gauge of
signal transduction triggered by Fsk and Dex, because the
mper1 promoter contains functional CRE and glucocorticoid
response element sites within the 3.0-kb region [33,47]. We
examined the acute effect of Fsk and Dex on mper1 promoter
activity in Rat1/P3.0kb-mper1::dLuc cells (Figure 10A and 10B).
Continuous treatment with Fsk rapidly and strongly activated
the mper1 promoter, and the maximum activity level (3.4-fold,
[3.40 6 0.24, n¼3]) was reached 2.4 h (2.44 6 0.10, n¼3) after
Fsk was added. On the other hand, Dex took 8.5 h (8.50 6
0.44, n ¼ 3) to increase the mper1 promoter activity to a peak
value, which was only 1.8-fold (1.82 6 0.11, n ¼ 3) larger than
the initial level. Unlike the rapid inactivation exhibited by Fsk
treatment, Dex treatment led to a prolonged activation (see
the plateau after 8.5 h).
We also examined the effects of continuous treatments
with Fsk and Dex on the activity of mper2 and bmal1 promoter/
reporters. The 1.7-kb region of the mper2 promoter contained
a nonfunctional CRE site [33] and no canonical glucocorti-
coid response element site. Moreover, we found neither CRE
nor glucocorticoid response element consensus sequences on
the 0.9-kb promoter of bmal1. As expected, neither promoter
was affected acutely by Fsk and Dex (Figure 10C–10H; note
that the time scales of Figure 10A–10D are 0–10 h, whereas
the time scales of Figure 10E–10H are 0–32 h.) The effects of
Fsk and Dex on the long-term circadian expression of the
mper2 and bmal1 promoter/reporters were similar to that
described before: earlier phase and low-amplitude oscilla-
tions initiated by Fsk, and delayed phase and high-amplitude
oscillations stimulated by Dex (Figure 10C–10H).
PRCs for Fsk and Dex treatments
In addition to the kinetics of action, differences in the phase
of oscillations initiated by Fsk vs. Dex could be related to their
phase-resetting properties. This possibility was tested by
measuring phase response curves (PRCs) to pulses of Fsk or
Dex. Conﬂuent cultures of Rat1/Pmper2::dLuc cells were
shocked with 50% horse serum, and treated with 2-h pulses
of 10 lM Fsk and 100 nM Dex (in parallel with pulses of
solvents as controls) at different phases during the second
cycle (day 2). The phases corrected for the minor shifts evoked
by the solvent controls were plotted in hours after the serum
shock and depicted in Figure 11. Comparison of the Fsk-
stimulated PRC with that stimulated by Dex showed that the
magnitude of the phase-shifts caused by 10 lM Fsk is smaller
than those by 100 nM Dex and that the two PRCs are phased
differently—the ‘‘breakpoint’’ for the Fsk PRC is at approx-
imately 37 h after serum shock, whereas that for Dex is about 3
h earlier, at approximately 34 h after serum shock (Figure 11).
Because the PRCs for Fsk vs. Dex are phased differently, the
phase of Rat-1 cells treated with these stimuli will initiate
rhythms with different phases, as observed in Figures 3, 7, and
8 and as tabulated in Tables 1–3. What happens when cells are
Figure 7. Stimulation of High-Amplitude Rhythmicity in Rat-1 Cells
Rat-1/Pmper2::dLuc reporter cells were treated with either solvent
controls (DMSO or EtOH) or the specified treatments (Fsk or Dex) for 2
h before beginning to monitor luminescence. Time 0 is the onset of
stimulation. Three replicates for the same treatments are shown in each
graph. (A) 0.1 % DMSO (solvent control for 10 lM Fsk). (B) 10 lM Fsk. (C)
0.001% EtOH (solvent control for 100 nM Dex). (D) 100 nM Dex.
DOI: 10.1371/journal.pcbi.0020136.g007
Table 2. Summary of Quantification Analysis of Experiments in Figure 7
Treatment RAE Rhythmic Sample N
(Total N)
Period (h) Phase (h) Amp (a) Norm Amp
(a/Mean y)
0.1% DMSO 0.142 6 0.063 3 (10) 22.82 6 0.41  8.32 6 0.85 223.5 6 131.3 0.104 6 0.033
10 lM Fsk 0.050 6 0.019 10 (10) 22.71 6 0.38  1.56 6 1.38 269.1 6 68.6 0.255 6 0.059
t test 0.0004
a 0.9489 0.0211
a 0.0210
a 0.0082
a
0.001% EtOH 0.118 6 0.046 6 (10) 22.62 6 0.45  7.32 6 2.24 178.3 6 183.4 0.062 6 0.044
100 nM Dex 0.051 6 0.019 10 (10) 22.56 6 0.28  9.93 6 1.29 506.3 6 187.5 0.307 6 0.052
t test 0.0009
a 0.4356 0.0335
a 0.0050
a 0.0004
a
t test a Fsk 0.9083 ,0.0001
a 0.0016
a 0.0209
a
Onset of the stimulation is used as a reference point. Phase was defined as described in Protocol S1. Oscillatory amplitude (a) and normalized amplitude (‘‘Norm Amp’’) were calculated
between hours 36–60 as explained in the Materials and Methods section. Means 6 SD are shown (N ¼ 10 from four independent experiments).
aSignificance (p , 0.05) in two-sided t test. t test was performed between a solvent control and experimental drug (p-value). It was also performed between Fsk and Dex (p-value a Fsk).
DOI: 10.1371/journal.pcbi.0020136.t002
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Circadian Gene Expression in Fibroblaststreated with both Fsk and Dex? Figure 12 shows that
costimulation with both Fsk and Dex results in a phase
relationship that is intermediate between those evoked by Fsk
or Dex alone: the phase elicited by Fsk is 2.92 6 0.79 (n¼5),
and that elicited by Dex alone is 9.95 6 0.26 (n¼6), whereas
the rhythms initiated by Rat-1 cells costimulated by both Fsk
and Dex establish an intermediate phase of  7.60 6 1.26 (n ¼
5). A t test showed a signiﬁcant difference (p , 0.01) between
Fsk vs. Fskþ Dex and between Dex vs. FskþDex.
Discussion
Different Treatments Evoke Rhythms with Varying
Characteristics
The present study demonstrates that the various treat-
ments used by previous researchers to initiate rhythms in
ﬁbroblasts can lead to a variety of oscillatory amplitudes and
phases (Figure 3). As assessed by RAE values (considering only
those with RAE , 0.123, indicative of statistically signiﬁcant
rhythmicity), rhythmicity was initiated by all ten compounds
presently considered (serum, Dex, ionomycin, PMA, Fsk, 8-
bromo-cAMP, EGF, basic FGF [bFGF], ET-1, and PGE2).
Whereas the solvent controls also elicited weak oscillations, in
all likelihood these rhythms arose not as a consequence of the
solvents per se, but rather the transfer from growth medium
(containing 5% fetal bovine serum [FBS]) to fresh assay
medium (containing 10% FBS), a procedure employed for
both control and experimental samples (see also [12]). These
weak oscillations, induced by media transfer, were charac-
terized by RAE values very similar to the RAE values
determined empirically to be expected for constitutively
expressed markers (i.e., SV40) in this Rat-1 ﬁbroblast model
system.
Our amplitude analyses indicated that serum, Dex, Fsk, and
EGF were the most effective inducers in generating high-
amplitude rhythms in Rat-1 cells. Intriguingly, these treat-
ments also initiated rhythms with different phase relation-
ships (see below). Based upon a predicted ultimate action on
CREB phosphorylation and transcription activation from
CRE sites [33], we initially expected that Fsk, 8-bromo-cAMP
(a potent protein kinase A activator), EGF, bFGF (factors for
the receptor tyrosine kinase–mediated mitogen-activated
protein kinase pathway), and ET-1 (an activator of the
protein kinase C–activated mitogen-activated protein kinase
pathway) would have had relatively equivalent effects.
However, of this group of activators, only Fsk and EGF
initiated statistically signiﬁcant rhythms (of signiﬁcantly
higher amplitude than the nonsigniﬁcant rhythms elicited
by 8-bromo-cAMP, EGF, bFGF, and ET-1) (Figures 3 and 6,
and Table 1).
These differences are likely to be due to both (1) different
efﬁcacies in activating the CREB phosphorylation pathway
and (2) the certitude that many of these treatments activated
various secondary pathways in addition to those that
terminate on CREB phosphorylation. For example, direct
addition of the substrate cAMP (8-bromo-cAMP) usually
requires relatively high concentrations (in the range of 0.1–
2.0 mM) to elicit a response so as to overcome poor
membrane permeability. Fsk, on the other hand, at much
lower concentrations (1–20 lM), enhances the activity of
adenylyl cyclase, the enzyme that subsequently produces
more locally high concentrations of cAMP that can act upon
protein kinase A.
Another reason for the observed differences in efﬁcacy
among the CREB-activating treatments and for the differ-
ences between our study and other studies is probably related
to the fact that the cell line used in our investigation (Rat-1
cells) likely expresses a different ensemble of genes encoding
either receptors and/or downstream signaling-pathway pro-
teins than did the NIH3T3 cells used by Akashi and Nishida
[8] or the primary ﬁbroblasts used by Yagita et al. [45].
Speciﬁcally, Rat-1 cells do not express the PGE2 receptor EP-
1, whereas NIH3T3 cells do [17,23]. Therefore, NIH3T3 cells
have the potential to respond to PGE2 robustly, whereas Rat-1
cells would not be expected to do so (Table 1). Finally,
another explanation for the differences between our study
Table 3. Summary of Quantification Analysis of Experiments in Figure 8
Treatment Duration RAE Rhythmic Sample N
(Total N)
Period (h) Phase (h) Amp (a) Norm Amp (a/Mean y)
No treatment 0 h 0.105 6 0.040 4 (6) 23.45 6 0.29  4.00 6 1.05 185.5 6 39.2 0.087 6 0.014
10 lM Fsk
0.5 h 0.049 6 0.016 6 (6) 23.23 6 0.32  0.71 6 0.53 225.4 6 66.5 0.251 6 0.011
1.0 h 0.040 6 0.009 6 (6) 23.26 6 0.15  0.86 6 0.31 240.2 6 38.1 0.257 6 0.016
2.0 h 0.039 6 0.013 6 (6) 23.07 6 0.19  0.99 6 0.22 293.7 6 96.4 0.299 6 0.018
4.0 h 0.046 6 0.009 6 (6) 23.06 6 0.20  0.69 6 0.65 365.9 6 106.9 0.331 6 0.024
ANOVA ,0.0001
a 0.0989 ,0.0001
a 0.0091
a ,0.0001
a
Dunnett’s
a (all vs. 0 h) (all vs. 0 h) (4 h vs. 0 h) (all vs. 0 h)
100 nM Dex
0.5 h 0.051 6 0.025 6 (6) 22.83 6 0.31  8.36 6 1.07 503.2 6 164.6 0.339 6 0.059
1.0 h 0.042 6 0.006 6 (6) 22.79 6 0.08  8.50 6 0.54 486.4 6 157.3 0.330 6 0.052
2.0 h 0.049 6 0.007 6 (6) 22.79 6 0.20  8.43 6 0.92 449.6 6 59.3 0.319 6 0.042
4.0 h 0.057 6 0.018 6 (6) 22.69 6 0.34  9.45 6 1.22 468.2 6 119.3 0.282 6 0.024
ANOVA 0.0005
a 0.0019
a ,0.0001
a 0.0052
a ,0.0001
a
Dunnett’s
a (all vs. 0 h) (all vs. 0 h) (all vs. 0 h) (all vs. 0 h) (all vs. 0 h)
Onset of the stimulation is used as a reference point. Phase was defined as described in Protocol S1. Oscillatory amplitude (a) and normalized amplitude (‘‘Norm Amp’’) were calculated
between hours 36–60 as explained in the Materials and Methods section. Shown is the mean 6 SD (N ¼ 6 from two independent experiments).
aSignificance (p , 0.05) in ANOVA, followed by Dunnett’s multiple comparisons test.
DOI: 10.1371/journal.pcbi.0020136.t003
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Circadian Gene Expression in Fibroblastsand other studies may be related to differences in the
ingredients used in the assay medium. For example, in our
previous paper [15], we compared the inclusion of FBS with
the serum-free supplement B27. When B27 is included in the
assay medium, simple medium changes elicit signiﬁcant
rhythmicity [15,48]. Some earlier studies used serum-free
medium, and it is possible that our inclusion of 10% FBS in
this investigation may have masked relatively subtle effects
that were elicited by treatments used in prior studies using
serum-free medium. We included FBS in our assay medium
because it allows cell viability to be extended so that we can
measure more cycles. Finally, the source of DMEM can affect
the assay; we have found a difference in the free-running
rhythm when Rat-1 cells are assayed in DMEM obtained from
GIBCO vs. Sigma (see Table 1 and Materials and Methods),
and there might be other unreported consequences of using
DMEM from different sources.
Comparison of Quantitative Methods for Analyzing
Rhythmic Patterns
Our present conclusions were made possible by a quanti-
tative analysis that employed a combined approach in which
Figure 8. Time-Dependent Stimulation Effect of Two Drugs on the
Initiation of Rhythmicity in Rat-1/Pmper2::dLuc Reporter Cells
Rat-1/Pmper2::dLuc reporter cells were treated with either 10 lM Fsk or
100 nM Dex for the indicated period of time before monitoring
luminescence rhythms. 0 h indicates no drug treatment (only a medium
change). Time 0 is the onset of stimulation. Three replicates from a larger
data set of the same treatments are shown in each graph (total N ¼ 6).
(A) Bioluminescence traces of 6 d of continuous measurements. Left
panel, 10 lM Fsk; right panel, 100 nM Dex. The graph for the ‘‘0h ’’
control data is repeated with different ordinal scales for the Fsk and Dex
columns to aid visualization (the ordinal scale is expanded for the Fsk
column).
(B) Figure 6A is rescaled to show the first 3 d. The scale for the ordinate is
held constant in this panel.
DOI: 10.1371/journal.pcbi.0020136.g008
Figure 9. Histogram Representation of the Oscillatory Amplitude
Calculations in Table 2
The gray bar is from 10 lM Fsk data; the clear bar is from 100 nM Dex
data. Error bars are 6 SD. *Statistical significance (p , 0.05) as compared
to the medium change (0 h) control. (A) Absolute oscillatory amplitude.
(B) Normalized oscillatory amplitude.
DOI: 10.1371/journal.pcbi.0020136.g009
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Circadian Gene Expression in Fibroblaststhe FFT-NLLS rhythms analysis procedure [25] was con-
ducted along with an objective data preprocessing strategy
that successfully eliminated mean and variance non-statio-
narities in our observed Pmper2::dLuc reporter rhythms. The
implementation of this combined strategy permitted reliable
assessment, in objective statistical terms, of both (1) the
degree of expressed rhythmicity (as assessed by a statistical
measure of rhythmic determination, the FFT-NLLS RAE) and
(2) the absolute and normalized magnitude of oscillatory
amplitude. Both goals were achieved because this strategy not
only (1) objectively eliminated baseline drift (i.e., mean non-
stationarities), but also (2) surmounted the otherwise con-
founding complications of time-dependent oscillatory damp-
ing (i.e., variance non-stationarities), both of which have been
reported previously as common occurrences in observed
peripheral tissue rhythms [4,15]. As a consequence, we were
able to successfully assess, on a statistical basis, the strength of
the various treatments in both (1) initiating ensemble
rhythmicity as well as (2) the magnitude of the resulting
oscillations.
There are two major differences between the current
method described herein and the previous FFT-NLLS
method for analyzing chronobiological data that was created
by one of us (M.S.) [25]. One difference is the application of
an aggressive detrending procedure that effectively reduces
mean and variance non-stationarities in a model-independ-
ent manner prior to the FFT-NLLS analysis (this part of the
procedure is called DTRNDANL—see Protocol S1). We found
this to be necessary because the extent of the non-
stationarities in our original data was such that analysis
without the DTRNDANL preprocessing produced results
prone to bias (i.e., FFT-NLLS was unable to handle the
original data reliably). The other difference from the
previous method [25] is that the current procedure also
characterized absolute oscillatory amplitude magnitudes for
subsequent interpretation. This was done by implementing
the concept underlying FFT-NLLS, except restricted to ﬁrst
order (i.e., a single-cosine wave–functional representation).
Figure 10. Effect of Continuous Stimulation by Fsk and Dex
Promoter activities of P3.0kb-mper1,P mper2,P bmal1 (Rat-1 cell line nos.
5–100, 3–72, and 5–66, respectively) were monitored in the continuous
presence of either 10 lM Fsk or 100 nM Dex. Time 0 is when the Fsk/Dex
was added. Three replicates are shown for each treatment.
(A) Rat-1/P3.0kb-mper1::dLuc cells in the continuous presence of 10 lM
Fsk.
(B) Rat-1/P3.0kb-mper1::dLuc cells in the continuous presence of 100 nM
Dex.
(C) Rat-1/Pmper2::dLuc cells in the continuous presence of 10 lM Fsk. NF,
nonfunctional.
(D) Rat-1/Pmper2::dLuc cells in the continuous presence of 100 nM Dex.
(E) Same as (C), except the time scale was expanded to 32 h. Arrows
indicate the initiation of rhythmic components.
(F) Same as (D), except the time scale was expanded to 32 h. Arrows
indicate the initiation of rhythmic components.
(G) Rat-1/Pbmal1::dLuc cells in the continuous presence of 10 lM Fsk.
(H) Rat-1/Pbmal1::dLuc cells in the continuous presence of 100 nM Dex.
DOI: 10.1371/journal.pcbi.0020136.g010
Figure 11. PRCs for Fsk versus Dex in Rat-1 Cells
Confluent Rat-1/Pmper2::dLuc cells were shocked with 50% horse serum
at time 0. At the indicated circadian times during the second cycle (Day
2), cultures were treated for 2 h with either 10 lM Fsk (red line) in parallel
with its solvent control (0.1% DMSO, gray line) or with 100 nM Dex (blue
line) in parallel with its solvent control (0.001% EtOH, gray line). A
representative trace for treatment and control is shown in panels (A), (B),
(D), and (E). PRCs are plotted as phase shifts on the ordinate (delay shifts
plotted as negative values, advance shifts as positive values) versus time
after the horse serum (HS) treatment on the abscissa.
(A) Pulse (2 h) of 10 lM Fsk or of 0.1% DMSO control at hour 34.6.
(B) Pulse (2 h) of 10 lM Fsk or of 0.1% DMSO control at hour 45.9.
(C) PRC for 10 lM Fsk pulses. Phases were corrected for the shifts by 0.1%
DMSO.
(D) Pulse (2 h) of 100 nM Dex or of 0.001% EtOH control at hour 34.6.
(E) Pulse (2 h) of 100 nM Dex or of 0.001% EtOH control at hour 45.9.
(F) PRC for 100 nM Dex pulses. Phases were corrected for the shifts by
0.001% EtOH.
DOI: 10.1371/journal.pcbi.0020136.g011
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Circadian Gene Expression in FibroblastsOur data acquisition system in this study was the Lumi-
Cycle, marketed by Actimetrics (Wilmette, Illinois, United
States). There is a convenient analysis package that is
included with the LumiCycle for detrending and period/
phase analyses. Our method described herein differs from
that included with the LumiCycle in several respects. We use a
more aggressive detrending algorithm (DTRNDANL) that is
model independent and objective because the only user-
speciﬁed variable is the ﬁlter period, whereas the detrending
LumiCycle program models baseline drift as a polynomial of
user-speciﬁed order (a subjective and potentially arbitrary
process; see Protocol S1). Moreover, our analytical procedure
performs a statistical assessment of model parameter con-
ﬁdence limits and rhythmic signiﬁcance by way of RAE from
the FFT-NLLS procedure (see Protocol S1). As described in
Protocol S1, the LumiCycle’s software includes several
methods for period analysis, but most do not assess statistical
signiﬁcance or conﬁdence (with the exception of chi-square
periodograms, which can reliably produce assessments of
signiﬁcance, but only for truly mean- and variance-stationary
data). The current analysis procedure has been optimized for
(1) considering statistical issues regarding relatively subtle
differences among conditions in chronobiological data and
(2) discerning the magnitude of rhythmic amplitude or
‘‘strength’’ (in particular, RAE helps answer the question,
‘‘Is there a rhythm in that data...or not?’’).
What Does ‘‘Oscillatory Amplitude’’ Reflect?
The underlying basis for our observation that some
treatments evoke higher amplitude rhythms than others is,
in all likelihood, related to the contributions of two
combined effects: (1) ensemble synchronization of cell
populations; and (2) cellular factors inﬂuencing the rhyth-
micity of individual cells.
Regarding population effects, Schibler and coworkers [22]
and Welsh and coworkers [48] recently reported biolumines-
cence imaging experiments on individual cells in which they
persuasively demonstrated that rhythmic damping in their
cell cultures was predominantly due to phase-desynchroniza-
tion of individually oscillating cells. These reports indicated
that the rhythmicity manifested in an ensemble of cultured
cells is a result of the resynchronization of individually
oscillating, but asynchronous, cells. By this mechanism,
initiation of rhythmicity in cell cultures by signaling stimuli
would be due to phase-resetting within a population of
individually oscillating cells. As such, differences in oscil-
latory amplitude elicited by different treatments would be a
reﬂection of the phase-shifting and coordinating efﬁcacy of
the various treatments.
The second relevant effect is cellular. Differences in
oscillatory amplitude in cell cultures will also reﬂect the
amplitude of the oscillation in each individual cell. In this
case, the different stimuli that initiate circadian oscillations
of different oscillatory strength would be inferred to invoke
different genetic expression patterns that ultimately result in
oscillations of ‘‘clockwork’’ genes of varying amplitude. On
the basis of the change in waveform/bandwidth of Pmper1::Luc
rhythms as they damp in Rat-1 cell populations, we previously
proposed that damping of the rhythms is possibly due to a
progressive decrease of the Rat-1 pacemaker’s amplitude in
each cell over time [15]. Whereas the aforementioned studies
suggest that desynchronization among oscillating cells is the
predominant basis for the progressive decline of oscillatory
amplitude in populations of cells [22,48], differential oscil-
latory amplitudes at the cellular level cannot be ruled out as
also playing a contributory role.
Two Distinct Pathways Can Initiate Circadian Expression in
Fibroblasts
We found that both Fsk and Dex elicit high-amplitude
rhythmicity in Rat-1 ﬁbroblasts, so these cells must express
receptor/signaling components that allow responsiveness to
these two compounds (other studies conﬁrm this conclusion
[10,43]). However, quantitative analyses of Fsk- and Dex-
induced rhythms revealed several distinct characteristics. A
Figure 12. Comparison of Phases Initiated by a Combination of Fsk and
Dex Stimuli
Rat-1/Pmper2::dLuc cells were treated with 10 lM Fsk or 100 nM Dex or
10 lM Fskþ100 nM Dex for 2 h. The phases of rhythms initated by each
treatment were: Fsk ¼  2.92 6 0.79 (n ¼ 5), Dex ¼  9.95 6 0.26 (n ¼ 6),
and FskþDex¼ 7.60 6 1.26 (n¼5). Time 0 is the onset of stimulation.
Three replicate measurements are shown for each treatment. (A) 10 lM
Fsk. (B) 100 nM Dex. (C) 10 lM Fsk þ 100 nM Dex.
DOI: 10.1371/journal.pcbi.0020136.g012
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Circadian Gene Expression in Fibroblastssigniﬁcant phase angle difference was found between Fsk and
Dex treatments (7.44 h difference after 2-h treatments; Figure
8 and Table 3) that is attributable to the phase angle
difference of PRCs evoked by these treatments (Figure 11).
Also, the magnitude of the oscillatory amplitude was
consistently larger with Dex treatment than with Fsk treat-
ment for all incubation periods (Figure 8 and Table 3). Our
time-course analyses of Fsk treatment demonstrated that
longer incubation times elicited progressively larger oscil-
latory amplitudes (Figure 8 and Table 3), implying that 30-
min treatment with 10 lM Fsk was below the saturation
threshold and longer treatments are needed for effective
population synchronization and/or cellular initiation by the
cAMP pathway. On the other hand, Dex stimulation showed a
different trend, whereby 100 nM Dex for 30 min appeared to
be saturating for maximal population synchronization and/or
cellular initiation. These phase and amplitude differences
clearly suggest that the resetting and synchronization
mechanisms of Fsk and Dex are different, as is graphically
demonstrated by the PRCs shown in Figure 11.
These phase and amplitude differences are likely to be a
consequence of (1) the magnitude/kinetics of the circadian gene
expression that isactivated, and/or (2)the different repertoire of
genes activated by Fsk vs. Dex. These distinct patterns of gene
expression subsequently orchestrate the resetting character-
istics observed in the present study. Per1 promoter activity
serves as an indicator of the differential activation of core
circadian clock genes, as well as of immediate early genes, both
ofwhich are importantexamples ofcoordinate regulation.Fsk
is expected to act primarily via CREB phosphorylation,
whereas Dex acts via the GR pathway, both of which ultimately
modulate a wide variety of transcriptional activities [49–51].
Transcriptional activation by CREB and GR generally begins
within5–30 minof stimulus onset [44,50,52]. However,Fskand
Dex showed different kinetics in activating per1, in which Fsk
showedrapid/strongactivationwhereas Dexshowedslow/weak
activation(Figure10Aand10B).Ourresultsareconsistentwith
those of Balsalobre et al [10], who measured the induction of
rper1 mRNA in response to Fsk and Dex. They also found that
Fskrapidlyinducedrper1mRNA,reachingmaximallevelsat1–
1.5 h, while the Dex response was considerably slower [10]. For
Fsk-inducedrhythms,therapidinductionkineticsweobserved
(Figure 10) were likely due to acute induction of a set of CREB-
induced genes (including per1 itself), which subsequently
rapidly initiate rhythmicity. On the other hand, the relatively
slower kinetics of per1 gene induction by the GR pathway are
consistent with Dex-induced rhythms, manifesting a delayed
phase. An additional component is that the level of genes that
are activated by Fsk and Dex may affect circadian gene
expression by negative feedback. For instance, per1 is a
repressor of circadian oscillations [1] and thus its strong
induction (e.g., by 10 lM Fsk) may have a negative effect on the
overall gene expression (e.g., [7,10,44]). Therefore, the differ-
ences between Fsk- and Dex-induced rhythms observed in this
study are possibly the result of the treatment-speciﬁc kinetics
of gene expression and of the different sets of genes that are
activated by Fsk vs. Dex.
Implications of Different Signaling Mechanisms Elicited by
Fsk versus Dex
ThephaseangledifferencewehaveobservedbetweenFskvs.
Dex induction in Rat-1 cells may help explain the 3–9 h later
phase of rhythms in peripheral tissues relative to those in the
SCN [36,53,54]. Because the SCN lacks GRs [43,55,56], there is
likely to be a fundamental difference in the resetting
mechanisms in SCN relative to peripheral tissues (at least,
with those expressing GRs). Photically stimulated CREB (via
glutamate,PACAP,Ca
þþ,andproteinkinaseA,etc.)likelyplays
a predominant role in SCN, whereas peripheral tissues are
more likely to be responding to humoral signals that activate
CREB pathways, as well as glucocorticoid pathways (and
probably others as well). This concept is depicted in Figure
12. A tissue that is receptive to signaling by the CREB pathway
alone might behave analogously to that of Rat-1 cells treated
withFskalone,whereasaperipheraltissuethatisresponsiveto
CREB signaling and multiple other pathways might behave
analogouslytothatofRat-1cellstreatedwithbothFskandDex
(Figure 12). The phase of cells treated with FskþDex (and Dex
alone)arelaterthanthoseofcellstreatedwithFskalone.These
differential effects may help explain the speciﬁc phase angle
differencesamongindividual tissuesandorgans,eachofwhich
utilize unique signaling pathways based on different sets and
distributions of expressed receptors and activators.
Materials and Methods
Plasmid constructs. The promoter/regulatory region of each
construct [15,32–34,36] along with ﬁreﬂy luciferase cDNA was
subcloned into pcDNA3.1/Hygro
þ vectors (Invitrogen, Carlsbad,
California, United States) so that (1) the luciferase cDNA was in
frame and (2) the 59 end of the promoter was protected by
transcription termination (see [15]). Destabilized luciferase (dLuc)
was created by attaching a PEST sequence fragment from the mouse
ornithine decarboxylase gene before the terminal codon of luciferase
(as in [13,16]). For a constitutive reporter, pMOS/Psv40::dLuc was
prepared so that the selection gene cassette (Pcmv::hyg::SV40pA)
preceded the reporter cassette (Psv40::dLuc::BGHpA), which was then
capped by a transcriptional terminator. This design facilitated the
identiﬁcation of stable transformants and minimized possible effects
of the integration site on the activity of the promoter of interest.
Cell culture and stable transfection. Rat-1 ﬁbroblast cells (a
generous gift from Dr. Michael Bishop) were cultured as previously
described [15]. Stable transfection and selection of hygromycin-
resistant colonies was also done as previously described [15], except
that LipoFectamine 2000 (GIBCO, San Diego, California, United
States) was used for transfection. To screen for stable Pmper2::dLuc
reporter lines,thefollowingcriteriawereemployed:(1)thelevel ofthe
reporter’s signal was required to be above the background of the
recording equipment (. 100 cps in the LumiCycle, whose dark counts
were 30–60 cps); (2) when assayed for circadian rhythmicity at 100%
conﬂuency, the stable clones were to exhibit a rhythm for at least two
cycles, as conﬁrmed by a transient transfection assay (unpublished
data) and also as shown for mper2 mRNA expression by Balsalobre et
al. [7]; (3) there were to be no growth retardation or morphological
alteration that may have arisen from the random insertion of the DNA
construct; and (4) the clones were to exhibit a reproducible circadian
expression assay. Most experiments reported here used a line called
Rat1/Pmper2::dLuc (line no. 3–72), which was one of the lines that
reproducibly showed a high-amplitude luminescence rhythm.
Real-time bioluminescence monitoring assay. Fsk (F6886; Sigma,
St. Louis, Missouri, United States) was dissolved in DMSO and Dex
(D1756; Sigma) was dissolved in EtOH. Approximately 3–5310
5 cells/
35-mm dish were seeded at least 6 d prior to the experiment. Before
recording, the cells were treated with 10 lM Fsk (ﬁnal DMSO
concentration of 0.1%) or 100 nM Dex (ﬁnal EtOH concentration of
0.001%) for the indicated period of time (2 h if not otherwise
speciﬁed). At the end of each treatment, the medium was replaced
with assay medium (DMEM lacking phenol red [catalog no. 13000–
021; GIBCO] supplemented with 10% FBS [no. 16000–044; GIBCO],
10 mM HEPES [pH 7.2], antibiotics [50 U/ml penicillin, 50 lg/ml
streptomycin], and 0.1 mM luciferin [Promega, Madison, Wisconsin,
United States]). Because GIBCO stopped producing DMEM no.
13000–021 during this study, DMEM no. D2902 from Sigma
supplemented with 3.5 g/l glucose and 350 mg/l NaHCO3 was used
in later experiments (the change of source for the DMEM medium
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Table 1 vs. Table 2 and Table 3; the data of Table 1 were obtained
using DMEM from Sigma, while the data of Table 2 and Table 3 were
obtained using DMEM from GIBCO). Dishes were sealed with 40-mm
circular coverslips (40-mm circle no. 1, catalog no. 40CIR-1; VWR,
West Chester, Pennsylvania, United States) and a bead of silicon
grease.
All assays were done in a LumiCycle, which is a 32-channel
automated luminometer that was placed within a 36.5 8C incubator in
a temperature-controlled room. All samples were measured every 10
min with an integration time of 75 sec for at least 6 d.
Quantitative analysis of bioluminescence data. The raw data were
ﬁrst detrended to produce zero mean and constant (=1) variance. A
sliding 24-h window was moved across the entire time course. A
uniformly weighted linear regression correction (calculated within
each of the successive sliding 24-h windows) was subtracted from each
of the original raw data values and retained in program memory. This
was done across each of the sliding windows affecting each point,
after which each of the 24-h corrected values for each datapoint were
averaged and subsequently stored with their corresponding x values.
Data detrended by only this linear-regression correction strategy are
referred to as residing in detrended only (DTR) space. To additionally
correct for damping effects, each 24-h window of detrended data
(after the linear-regression correction step) was further divided by
the standard deviation within each corresponding sliding 24-h
window and retained in program memory. Averaging was then
performed again as described above to produce a detrended time
series of constant unit variance (these data are referred to as residing
in standard normal deviate [SND] space). This procedure removed
mean non-stationarities (i.e., baseline drifting) from the raw data and,
if the data were reported in SND space, variance non-stationarities
(i.e., damping) were also removed (Figure 4).
After detrending, all data were analyzed for period and phase by
FFT-NLLS analysis [25]. Onset of stimulation (e.g., Fsk, Dex, etc.), was
used to deﬁne time zero. Data within the ﬁrst 144 h after the onset of
stimulation were considered in the analysis. Phase was deﬁned as
described in Protocol S1. In addition to period and phase estimation,
the level of rhythmic determination was assessed by the RAE, which
was obtained by dividing the amplitude error by the most probable
amplitude estimate, and was expressed as a fractional value ranging
from 0 to 1.0, where ‘‘0’’ corresponds to a rhythmic component
known to inﬁnite precision (zero error), and ‘‘1.0’’ corresponds to a
rhythm that is not statistically signiﬁcant.
Based on the period and phase information from the SND space
analysis, oscillatory amplitude (a) was calculated by a linear least
squares estimation of DTR space data, according to the following
equation:
yðtÞ¼c0 þ acos
2pðt þ /Þ
s

ð1Þ
The measurement interval for our analyses in this paper was
restricted to hours 36–60, which corresponds to the interval after the
transient activation effect had decayed, but before signiﬁcant
damping of oscillatory amplitude was evident. The resultant absolute
amplitude value was used to compare the absolute oscillatory
strength exhibited by different samples. In order to compensate for
a possible variation between samples (e.g., resulting from differences
in total cell number, luminescence intensity, etc.), ‘‘normalized
amplitude’’ was also computed by dividing the absolute amplitude
(a) by background, which was calculated as an average of lumines-
cence intensity between 36–60 h in the raw data.
An RAE threshold value was employed to distinguish between (1)
the absence vs. (2) the presence of rhythmicity. The cut-off RAE
value was determined essentially as in Stanewsky et al. [46]. In the
mammalian case, we tested Psv40, a promoter that has been
determined to be nonrhythmic [13]. Rat-1 cells were stably trans-
fected with pMOS/Psv40::dLuc so that the linearized plasmids would
be randomly integrated throughout the genome, and were sub-
sequently pooled after selection. We prepared four independent
transfections with three different concentrations of pMOS/
Psv40::dLuc plasmid, and measured 96 samples for Fsk treatment
and 88 samples for Dex treatments, as each drug treatment caused
different expression patterning. Out of these samples, 95 and 88
samples were detected as rhythmic (periods ranged from 18–28 h).
The average RAE of these samples was 0.275 6 0.107 and 0.247 6
0.105, respectively. Assuming a normal distribution, 5% of the lowest
RAE values from Rat1/Psv40::dLuc represents the ‘‘strong rhythmic-
ity level’’ of the SV40 promoter. Based on the assumption that the
SV40 promoter is arhythmic, a critical RAE value was calculated to
be 0.124 for Fsk treatment and 0.123 for Dex treatment. We used
0.123 to be the threshold to deﬁne rhythmicity at a 95% conﬁdence
level. In this study, data whose RAE value was ,0.123 were judged to
be rhythmic. For a more detailed description of our method of
quantitative analysis as well as a brief description of the software
analysis package included with the LumiCycle, please see Protocol
S1.
Supporting Information
Protocol S1. Detailed Descriptions of Data Analysis Methods Used by
the Authors and as Included with the LumiCycle
Found at DOI: 10.1371/journal.pcbi.0020136.sd001 (36 KB DOC).
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